Cyclerion Therapeutics, Inc.
Company Stats
- Market Cap
- $149.8M
- as of Sep 30, 2026
- Shares Outstanding
- 4.7M
- Free Float
- 70.2%
Income Statement
- Revenue
- $2.1M
- Operating Income
- -$5.0M
- Net Income
- -$3.5M
- Revenue Growth, 3Y
- 91.1%
Balance Sheet
- Cash & Equivalents
- $3.2M
Returns & Capital
- SBC, 3Y Avg
- $711,000
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.1M | — | — |
| FY2024 | $2.0M | — | — |
| FY2023 | $0 | — | — |
| FY2022 | $297,000 | -$40.6M | -13673.7% |
| FY2021 | $3.9M | -$36.5M | -926.5% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 4, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.